Allergan's $2.4 billion dollar deal to acquire medical and cooling technology company ZELTIQ Aesthetics has successfully been completed, according to an announcement by the global pharmaceutical company.
In February 2017, Allergan revealed its plans to purchase ZELTIQ and its flagship CoolSculpting System, to broaden its product range to body contouring.
Now the deal has become official, with ZELTIQ stakeholders approving the transaction during its stakeholder meeting on April 27.
"We are thrilled to complete the acquisition of ZELTIQ, which immediately expands our world-class global aesthetic business into the highly-complementary and fast-growing body contouring segment," said Bill Meury, chief commercial officer of Allergan.
He added, "CoolSculpting gives Allergan the most comprehensive and dynamic portfolio of products for plastic surgeons, dermatologists and other aesthetic providers across the globe."